Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rangering i aksjer #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$4.04K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel Xeno Transplants Corporation (XENO)

Kategori

Historikk for aksjesplitt for Xeno Transplants Corporation (XENO)
Aksjen Xeno Transplants Corporation (symbol: XENO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 12, 2026.
Én XENO-aksje kjøpt før Aug 12, 2026 tilsvarer i dag 0 XENO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR